✨ Medicines Act Notices
NEW ZEALAND GAZETTE
No. 66
1530
Health
Medicines Act 1981
Consent to the Distribution of a New Medicine
Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicine set out in the Schedule hereto:
Schedule
| Name and Strength | Form | Name and Address of Manufacturer | Proprietary Name (if any) |
|---|---|---|---|
| Beclomethasone dipropionate 50 µg, 100 µg, 250 µg | Inhaler, aerosol. Metered | Norton (Waterford) Limited, Waterford Industrial Estate, Waterford, Eire | Beclazone Inhaler |
| Beclomethasone dipropionate 50 µg, 100 µg, 250 µg | Inhaler, aerosol. Metered | Norton (Waterford) Limited, Waterford Industrial Estate, Waterford, Eire | Beclazone Easi-Breathe Inhaler |
Dated this 30th day of April 1998.
G. R. BOYD, Chief Advisor, Regulation and Safety, pursuant to delegation given by the Minister of Health on the 20th day of February 1997.
go3240
Consent to the Distribution of a New Medicine
Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicine set out in the Schedule hereto:
Schedule
| Name and Strength | Form | Name and Address of Manufacturer | Proprietary Name (if any) |
|---|---|---|---|
| Flucloxacillin 250 mg, 500 mg | Capsule | Athlone Laboratories Limited, Ballymurray, Roscommon, Eire | HSS-Flucloxacillin |
Dated this 30th day of April 1998.
G. R. BOYD, Chief Advisor, Regulation and Safety, pursuant to delegation given by the Minister of Health on the 20th day of February 1997.
go3280
Consent to the Distribution of Changed Medicines
Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the changed medicines which were referred to the Minister of Health under the provisions of section 24 (5) of the Act, are set out in the Schedule hereto:
Schedule
| Name and Strength | Form | Name and Address of Manufacturer | Proprietary Name (if any) |
|---|---|---|---|
| Fentanyl citrate 25 µg/hour, 50 µg/hour, 75 µg/hour, 100 µg/hour | Transdermal patch | Alza Corporation, Vacaville, California, United States of America | Durogesic |
| Nicotine 10 mg | Inhalation, volatile liquid | Pharmacia AB., Helsingborg, Sweden | Nicorette Inhaler |
Dated this 7th day of May 1998.
G. R. BOYD, Chief Advisor, Regulation and Safety, pursuant to delegation given by the Minister of Health on the 20th day of February 1997.
go3297
Consent to the Distribution of a New Medicine
Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicine set out in the Schedule hereto:
Schedule
| Name and Strength | Form | Name and Address of Manufacturer | Proprietary Name (if any) |
|---|---|---|---|
| Candesartan cilexetil 4 mg, 8 mg, 16 mg | Tablet | Astra Pharmaceutical Production AB., Södertälje, Sweden | Atacand |
Next Page →
PDF embedding disabled (Crown copyright)
View this page online at:
VUW Te Waharoa —
NZ Gazette 1998, No 66
NZLII —
NZ Gazette 1998, No 66
✨ LLM interpretation of page content
🏥 Consent to the Distribution of a New Medicine
🏥 Health & Social Welfare30 April 1998
Medicines, Distribution, Beclomethasone dipropionate, Inhaler
- G. R. Boyd, Chief Advisor, Regulation and Safety
🏥 Consent to the Distribution of a New Medicine
🏥 Health & Social Welfare30 April 1998
Medicines, Distribution, Flucloxacillin, Capsule
- G. R. Boyd, Chief Advisor, Regulation and Safety
🏥 Consent to the Distribution of Changed Medicines
🏥 Health & Social Welfare7 May 1998
Medicines, Distribution, Fentanyl citrate, Nicotine, Transdermal patch, Inhalation
- G. R. Boyd, Chief Advisor, Regulation and Safety
🏥 Consent to the Distribution of a New Medicine
🏥 Health & Social Welfare7 May 1998
Medicines, Distribution, Candesartan cilexetil, Tablet
- G. R. Boyd, Chief Advisor, Regulation and Safety